B. Braun Melsungen AG requests supplements to agenda of the extraordinary general shareholders’ meeting on 3 June 2020

RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): AGM/EGM

B. Braun Melsungen AG requests supplements to agenda of the extraordinary general shareholders’ meeting on 3 June 2020

14-May-2020 / 21:50 CET/CEST

Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.


On 14 May 2020, the Management Board of RHÖN-KLINIKUM Aktiengesellschaft has received a request by the shareholder B. Braun Melsungen AG (“B. Braun“) for supplements to the agenda of the extraordinary general shareholders’ meeting on 3 June 2020. According to the request for supplements, B. Braun demands the following additional items be put on the agenda:

– presentation of the adopted annual financial statements and the approved consolidated financial statements as of 31 December 2019 (including management reports and report of the Supervisory Board for the 2019 financial year),

– resolution on the appropriation of the balance sheet profit, whereby B. Braun leaves it to the Management Board and the Supervisory Board to submit the proposal for the appropriation of profit published in the 2019 Annual Report,

– resolution on the discharge of the members of the Management Board and the shareholder representatives on the Supervisory Board for the 2019 financial year, and

– election of the shareholder representatives on the Supervisory Board, whereby it is proposed that the candidates already proposed by B. Braun in the request to convene the meeting shall be elected for the maximum term of office permitted by law.

The Management Board will diligently examine B. Braun’s request for supplements and take the legally required measures.


14-May-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: RHÖN-KLINIKUM Aktiengesellschaft
Salzburger Leite 1
97616 Bad Neustadt a.d.Saale
Germany
Phone: +49 (0)9771 – 65-0
Fax: +49 (0)9771 – 97 467
E-mail: rka@rhoen-klinikum-ag.com
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange
EQS News ID: 1045839

 
End of Announcement DGAP News Service

show this